header
welcomeeducationpeopleresearchcontact

>> welcome >> education >> perspectives on the future >>

EDUCATION

Perspectives on the Future of Pharmaceuticals Lunch Discussion Series

The purpose of the "Perspectives" Lunch Series is to create a forum for thoughtful roundtable discussion in brief presentations given by speakers from academia, industry, and government followed by extended discussion. Each presentation emphasizes the future needs and hurdles of drug design, development and delivery.

2007

Anne Skaja Robinson,
Department of Chemical Engineering, University of Delaware
Designing Proteins and Cells for Drug Screening
November 14, 2007

Wei-Shou Hu,
Department of Chemical Engineering and Materials Science, University of Minnesota
Metabolic Engineering for Protein Production
October 25, 2007

J. Brad Chaires,
James Grahem Brown Cancer Center, University of Louisville
Targeting Nucleic Acids
September 13, 2007

Kristi Anseth,
Howard Hughes Medical Center, University of Colorado at Boulder
Pharmaceutical Biomaterials
August 29, 2007

Robert Prud'homme,
Professor of Chemical Engineering, Princeton University
Nanoparticle Pharmaceuticals
April 18, 2007

Stanley Foster, MD, MPH,
Professor of Global Health, Emory University
Medical Therapies in Africa: The past, present, and future of measles in African children
March 29, 2007

Sidney Hecht, Chemistry,
University of Virginia
Discovery of Drugs that Target Mitochondrial Respiration
March 1, 2007

2006

Michael T. Bowser,
Department of Chemistry, University of Minnesota
The Future of Aptamers in Pharmaceutical Research
November 2, 2006

Antonios Mikos,
Department of Bioengineering, Rice University
Drug Delivery Systems for Tissue Engineering Applications
October 5, 2006

Samir Mitragotri,
Department of Chemical Engineering, University of California, Santa Barbara
High Throughput Screening Methods in Drug Delivery Applications
September 13, 2006

William Roush,
Kellogg School of Science and Technology, The Scripps Research Institute, Florida
Strategies to Address the 9% Problem
April 20, 2006

Jennifer Fiegal,
Division of Engineering and Applied Sciences, Harvard University
Barriers to Developing-World Health
February 15, 2006

2005

William Gerwick,
College of Pharmacy, Oregon State University
The Future of Pharmacy from the Sea
November 30, 2005

Jonathan Dordick,
Department of Chemical Engineering, Rensselaer Polytechnic Institute
Major Bottlenecks in the Pharmaceutical Industry
November 16, 2005

Dennis Liotta,
Department of Chemistry, Emory University
The Future of High-throughput Drug Discovery
October 25, 2005

Ajay Banga,
Chairman and Professor, Department of Pharmaceutical Sciences,
Mercer University Southern School of Pharmacy
The Future of Pharmaceutical Education
April 26, 2005

John Katzenellenbogen,
Swanlund Professor of Chemistry, University of Illinois at Urbana-Champaign
Steroid Hormones and Drug Design
February 17, 2005

Alan Minsk, Esq
Food and Drug Practice Team, Arnall Golden Gregory LLP
Nanotechnology, Nanomedicine, and Regulations
January 27, 2005

2004

Joseph LeDoux, PhD
Department of Biomedical Engineering, Georgia Tech/Emory
Gene Therapy
December 2, 2004

Janet Tamada,
Senior Director, Product and Process Development, Alexza MDC
Cost-Effective Drug Delivery for Unmet Needs
September 22, 2004

Mark Prausnitz, PhD
School of Chemical and Biomolecular Engineering, Georgia Tech
The Need for New Routes and Carriers for Drug Delivery
May 26, 2004

Sheldon May,
School of Chemistry and Biochemistry, Georgia Tech
Lessons and Perspectives from Two Excursions in Drug Design and Development
March 31, 2004

Andy Bommarius, PhD
School of Chemical and Biomolecular Engineering, Georgia Tech
Drug Screening and Processing
February 20, 2004




Center for Drug Design, Development and Delivery
Georgia Institute of Technology
Institute for Bioengineering & Bioscience
315 Ferst Drive
Atlanta, GA 30332-0363
Email Us